Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment-Reference-Cited by-同舟云学术

Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment

Published:2005-05-17 Issue:11 Volume:92 Page:1984-1988
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Luksch R,Podda M,Gandola L,Polastri D,Piva L,Castellani R,Collini P,Massimino M,Cefalo G,Terenziani M,Ferrari A,Casanova M,Spreafico F,Meazza C,Bozzi F,Marchianò A,Ravagnani F,Fossati-Bellani F

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602615.pdf

Reference27 articles.

1. Berthold F, Burdach S, Kremens B, Lampert F, Niethammer D, Riehm H, Ritter J, Treuner J, Utsch S, Zieschang J (1990) The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPOH (German Pediatric Oncology Society) experience. Klin Pädiatr 202: 262–269

2. Berthold F, Hero B (2000) Neuroblastoma. Current drug therapy recommendations as part of the total treatment approach. Drug 59: 1261–1277

3. Brodeur GM, Pritchard J, Berthold F, Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11: 1466–1477

4. Castel V, Canete A, Navarro S, Garcia-Miguel P, Melero C, Acha T, Navajas A, Badal MD (2001) Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results. Med Pediatr Oncol 37: 537–542

5. Cheung NV, Kushner BH, Cheung IY, Kramer K, Canete A, Gerald W, Bonilla MA, Finn R, Yeh SJ, Larson SM (1998) Anti-GD2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 16: 3053–3060

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review;Targeted Oncology;2024-02-24

2. Role of non-coding RNAs in neuroblastoma;Cancer Gene Therapy;2023-05-22

3. The Transcribed-Ultra Conserved Regions: Novel Non-Coding RNA Players in Neuroblastoma Progression;Non-Coding RNA;2019-06-04

4. Paediatric Tumours of Neuroendocrine/Peripheral Neuroectodermal Origin;Clinical Applications of Nuclear Medicine Targeted Therapy;2018

5. Neuroblastoma (Peripheral neuroblastic tumours);Critical Reviews in Oncology/Hematology;2016-11